Evidence map›Paper›PMID 41010413›Full record

ArticleLife (Basel, Switzerland)2025

Expression of a Tuberculosis-Associated Immunogenic Protein in

Gizem Kılıç, Burcu Saygıner, Muhammed Yusuf Yılmaz, Bilge Suyolcu Albayrak, Neda Tatlıoğlu, Ayça Tan, Tanil Kocagoz, Nihan Ünübol, Erkan Mozioğlu

Abstract read
In one paragraph

Article in Life (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Gizem KılıçDepartment of Medical Biotechnology, Institute of Health Sciences, Acibadem University, 34752 İstanbul, Türkiye.
Burcu SaygınerDepartment of Medical Biotechnology, Institute of Health Sciences, Acibadem University, 34752 İstanbul, Türkiye.
Muhammed Yusuf YılmazDepartment of Medical Biotechnology, Institute of Health Sciences, Acibadem University, 34752 İstanbul, Türkiye.ORCID 0009-0003-6292-5164
Bilge Suyolcu AlbayrakDepartment of Medical Biotechnology, Institute of Health Sciences, Acibadem University, 34752 İstanbul, Türkiye.
Neda TatlıoğluDepartment of Medical Biotechnology, Institute of Health Sciences, Acibadem University, 34752 İstanbul, Türkiye.ORCID 0000-0002-7521-6880
Ayça TanDepartment of Medical Biotechnology, Institute of Health Sciences, Acibadem University, 34752 İstanbul, Türkiye.ORCID 0000-0001-6179-2302
Tanil KocagozDepartment of Medical Biotechnology, Institute of Health Sciences, Acibadem University, 34752 İstanbul, Türkiye.ORCID 0000-0001-7211-2026
Nihan ÜnübolDepartment of Medical Biotechnology, Institute of Health Sciences, Acibadem University, 34752 İstanbul, Türkiye.ORCID 0000-0003-4644-112X
Erkan MozioğluDepartment of Medical Biotechnology, Institute of Health Sciences, Acibadem University, 34752 İstanbul, Türkiye.ORCID 0000-0002-3027-5166

Funding

TÜBİTAK TÜBİTAK-3501, Project Number: 121Z220.
6 · The paper itself

Abstract

It is estimated that one in four people worldwide carries

Indexed as

codon optimsationLICMPT64M. tuberculosisrecombinant protein

Identifiers

PMID41010413
PMCPMC12471812

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.